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C-NAP1Centrosome ampliﬁcation, which is a characteristic of cancer cells, has been understood as a driving force of
genetic instability in the development of cancer. In previous work, we demonstrated that TEIF (transcriptional
element-interacting factor) distributes in the centrosomes and regulates centrosome status under both physio-
logic and pathologic conditions. Here we identify TEIF as a downstream effector in EGF/PI3K/Akt signaling. The
addition of EGF or transfection of active Akt stimulates centrosome TEIF distribution, resulting in an increase of
centrosome splitting and ampliﬁcation, while inhibitors of either PI3K or Akt attenuate these changes in TEIF
and the associated centrosome status. A consensus motif for Akt phosphorylation (RHRVLT) proved to be in-
volved in centrosomal TEIF localization, and the 469-threonine of this motif may be phosphorylated by Akt
both in vitro and in vivo. Elimination of this phosphorylated site on TEIF caused reduced centrosome distribution
and centrosome splitting or ampliﬁcation. Moreover, TEIF closely co-localizedwith C-NAP1 at the proximal ends
of centrioles, and centriolar loading of TEIF stimulated by EGF/Akt could displace C-NAP1, resulting in centrosome
splitting. These ﬁndings reveal linkage of the EGF/PI3K/Akt signaling pathway to regulation of centrosome status
which may act as an oncogenic pathway and induce genetic instability in carcinogenesis.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The centrosome is composed of a pair of centrioles and
pericentriolar matrix (PCM), and serves as the main cellular microtu-
bule organizing center (MTOC). Centrosomes play a crucial role in the
equal partition of chromosomes during cell mitosis, and they therefore
must be precisely regulated to maintain accuracy of their function and
maintain correct numbers of chromosomes within the cell. Centrosome
ampliﬁcation, which is deﬁned as more than two centrosomes in one
cell or by centrosomehypertrophy and/or fragmentation, is characteris-
tic of many human cancers [1–4]. Centrosome ampliﬁcation is consid-
ered to be the driving force of genetic instability, as the multipolar
spindles which result from centrosome ampliﬁcation give rise to more
than two daughter cells and cause genetic imbalance [5,6]. Recent
research reveals that extra centrosomes may induce merotelic attach-
ment of the kinetochore allowing cells to bypass control by SAC (spindle
assembly checkpoint) activity resulting in aneuploidy, which is a
characteristic cancer cell phenotype [7,8]. Mechanisms related toience Foundation of China (No.
e Doctoral Program of Highercentrosome abnormalities in cancer have therefore been extensively
explored, and many aspects of these mechanisms have been deﬁned
[9,10]. Supernumerary centrosomes can simply arise from incomplete
cell division and cell fusion, but are more frequently induced by the
intrinsic regulating mechanism of centrosomal activity [11,12]. Over-
expression of matrix proteins, such as centrin, pericentrin and TACCS
(transforming acidic coiled-coil containing proteins) has been credited
with contributing to centrosomal abnormalities in tumorigenesis [4,5,
11,12]. However, themost important aspects of centrosomal abnormal-
ity involve the regulatory machinery which couples the cell cycle with
centrosome activity, which results from the function of many kinds of
genes and proteins. For example, inactivation of checkpoint genes,
such as ATM, p53 and BRCA1 [12–14], and over-expression of Aurora-
A or B have been shown to result in centrosome dysfunction [15–17].
At the same time, in order tomaintain a precise number of centrosomes,
their duplication is tightly controlled by coordination of centrosomal
proteins including a series of kinases PLK4 and Aurora-A together
with proteasome activity. This allows proper assembly of procentriolar
materials, and dysfunction of these molecules may cause over-
duplication of centrosomes [18]. In addition, duplicated centrosomes
are connected through a linker and maintain a status of cohesion until
centrosome separation occurs at the onset of mitosis. The disruption
of cohesion in interphase may induce premature separation of centro-
somes (centrosome splitting), and split centrosome may consequently
be prone to recruit procentriolar materials and form additional
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Table 1








GFP-TEIF-ΔEX + 15–786 aa 29% 7%
GFP-TEIF-ΔHX + 156–786 aa 25% 5%
GFP-TEIF-ΔFX + 365–786 aa 16% 3%
GFP-TEIF-ΔFP-1 + 365–546 aa 10% 2%
GFP-TEIF-ΔFP-2 − 367–621 aa 6% 1%
GFP-TEIF-ΔEF − 15–364 aa 5% 1%
GFP-TEIF-ΔEB − 15–177 aa 6% 2%
GFP-C3 − 0 8% 2%
Each of the above constructs was transfected and stained with γ-tubulin. A total of 1000
cells from each GFP-TEIF transfection were counted, and the percentage of centrosome
splitting or ampliﬁcationwas calculated .+:with centrosome localization;−: without cen-
trosome localization. These data represent an average of three independent experiments.
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on the relationship of oncogenic mutation and centrosome ampliﬁca-
tion, since oncogenic activation usually occurs in the early phase of
carcinogenesis in most human cancers [21,22]. K-ras mutation is in
fact able to induce centrosome ampliﬁcation and abnormal cell division
through cyclinD1/CDK4 andNek2a kinase [21],whilemutation of growth
factor receptor met and the tumor promoter 12-0-tetradecanoylphorbol
13-acetate (TPA) have also been shown to be inducers of centrosome
ampliﬁcation [22,23].
EGF/PI3K/Akt is a major oncogenic signaling pathway which is acti-
vated by genomic mutations of EGFR, PI3KCA, PTEN or Akt, and this
pathway is themost frequently detected promoting cancer cell growth,
progression and metastasis in human cancer [24,25]. This pathway has
become one of the most important targets for tumor therapy [26–29].
Mutation or over-expression of EGFRvIII induces centrosome ampliﬁca-
tion and chromosomal aberration,which can be synergistically enforced
by simultaneous PTEN loss in glial tumors [30,31]. In addition, activation
of Aurora-A kinase by Akt has proved to induce centrosome ampliﬁca-
tion and consequent chromosome abnormality in cancer cells [32,33].
However, the mechanism by which EGF/PI3K/Akt signaling and centro-
some activity are coupled is far from clear, despite a discovery in the
1980s which revealed that the addition of EGF enhances the separation
of centrosomes [34,35]. To date, there have been several studies regard-
ing EGF/PI3K/Akt signaling and its relation to centrosome activity and
abnormalities. It has been shown that Akt1 is necessary for centrosome
migration and spindle orientation in the early Drosophila melanogaster
embryo, which acts through GSK-3 (glycogen synthase kinase-3) [36].
The Akt1-interactive factor Aki1 (Akt kinase-interacting protein 1) lo-
calizes in the centrosome and regulates centrosome cohesion [37]. In
particular, it has further been shown that EGF can induce premature
centrosome separation in the early S phase and consequently promote
cell proliferation and survival [38]. In a recent study we have also dem-
onstrated that Akt regulates distribution of the cytoskeleton modulator
Girdin in the centrosome and midbody for participation in cell division
[39]. Nevertheless, a more detailed investigation of regulation of the
centrosome by EGF/PI3K/Akt signaling is warranted.
TEIF (transcriptional element-interacting factor) is a factor involved
in the regulation of telomerase for promotion of cell proliferation [40,
41]. In a previous study, we showed that a portion of TEIF distributes
at the centrosome and regulates its status under both physiological
conditions and carcinogenesis, but the molecular details of this process
remain to be worked out [42]. Careful analysis of the structure of TEIF
showed that it seems to lack kinase activity despite its kinase-like
structure [40], but putative phosphorylation sites for several kinases
including Akt were found in bioinformatical analysis. In addition, ex-
pression of TEIF in the centrosome reaches a high level upon release
from a double-thymidine block or by addition of serum after starvation
(unpublished data). We therefore hypothesize that TEIF is a down-
streameffector of EGF/PI3K/Akt signalingwhich serves in the regulation
of centrosome activity.
2. Material and methods
2.1. Cell culture
HeLa, MCF-7, U2OS and PC3M cells and a series of stably-transfected
HeLa cell lines expressing various segments of GFP-TEIF were cultured in
Dulbecco's modiﬁed Eagle medium (DMEM) supplemented with 10%
FBS at 37 °C in a 5% CO2 atmosphere. For EGF treatment, cells wereFig. 1. TEIF regulated centrosome activity. A. Construction of TEIF polypeptides. The various re
-ΔHX, -ΔFX, -ΔFP-1, -ΔEB and -ΔEF. “RHRVLT” indicates the putative consensus motif for Akt p
cells. HeLa cells with GFP-TEIF expression (green) were stained with γ-tubulin (red). The resu
effects of over-expressed TEIF on the centrosomes. His-tagged full length TEIF (pcDHis-TEIF). U
MCF-7 cells, whichwere stained with TEIF (green),γ-tubulin (red) and DAPI (blue). Lower pane
500 TEIF-transfected cellswere counted. Arrows indicate normal centrosome, arrowheads in solidserum starved for 16 h and were then stimulated with recombinant
human EGF (Sigma-Aldrich, Saint Louis, MO, USA) at a ﬁnal concentra-
tion of 100 ng/ml for a period of time as indicated. In some experiments
designated concentrations of LY294002 (Merck KGaA, Darmstadt,
Germany) and perifosine (Selleck Chemicals, Houston, TX, USA) were
added to the cultured cells after treatment with EGF.
2.2. Antibodies
Rabbit polyclonal anti-TEIF was described previously [42]. Mouse
monoclonal anti-γ-tubulin and anti-β-actin were purchased from
Sigma-Aldrich. Anti-Akt rabbit polyclonal antibody, rabbit monoclonal
anti-phospho-Akt Ser473 (pAkt), and anti-phospho-Akt substrate
(pAkt-MOTIF) were obtained from Cell Signaling Technology (Danvers,
MA, USA). Rabbit polyclonal anti-GFPwas purchased fromMBL Interna-
tional Corp. (Woburn, MA, USA) and mouse monoclonal anti-CerbB2
was from Dako (Glostrup, Denmark). Rabbit polyclonal antibody anti-
C-NAP1 was from Proteintech (Chicago, IL, USA), and anti-ninein, anti-
cenexin and anti-pericentrin were from Abcam (Cambridge, MA, USA).
2.3. Plasmid construction and transfection
Restriction enzyme fragments encoding various portions of TEIF
(Fig. 1A) were fused into pEGFP-C3 vectors (BD Biosciences Clontech,
Franklin Lakes, NJ, USA), and centrin2 was fused into pEGFP-C3 and
pDsRed2-C1 vectors (BD Biosciences Clontech, Franklin Lakes, NJ,
USA), generating in-frame constructs expressing fusion proteins. His-
tagged full length TEIF (pcDHis-TEIF) was constructed as described pre-
viously [42]. Transient transfection was carried out using Lipofectamine
2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's
recommendations. For generating stable cell lines, cells were cultured
in medium containing 800 μg/ml G418 (Sigma-Aldrich) and single
clones were isolated and expanded.
2.4. Immunoﬂuorescent microscopy
Cells grown on cover slides were ﬁxed with ice-cold methanol for 5
min, blocked with horse serum for 60 min, and then incubated with
anti-TEIF (1:300) and anti-γ-tubulin (1:500), C-NAP1 (1:100), ninein
(1:100), cenexin (1:100), or pericentrin (1:1000) at 4 °C overnight.
The slides were washed and further treated with FITC or TRITC-striction enzyme fragments of TEIF were fused to a GFP vector to generate GFP-TEIF-ΔEX,
hosphorylation. B. Representative images of centrosome status from GFP-TEIF-transfected
lts are representative of independent experiments repeated more than three times. C. The
pper panels: representative images of centrosome status from TEIF-transfected HeLa and
ls: quantiﬁcation of centrosome splitting and ampliﬁcation of the above cells and a total of
indicate centrosome splitting, and open arrowheads indicate centrosome ampliﬁcation (B, C).
Fig. 2. EGF/PI3K signaling stimulated TEIF-regulating centrosome status. HeLa cells and the stable cell line HeLa-GFP-TEIF-ΔHX were serum starved for 16 h and were then treated with
EGF (100 ng/ml) for 8 h, or together with LY294002 (10 μM). A, B. The effects of EGF on centrosome loading of TEIF and centrosome splitting and ampliﬁcation. Cells were labeled or
double-labeled with TEIF/GFP (green), anti-γ-tubulin antibody (red) and counterstained with DAPI (blue) for immunoﬂuorescent staining. The images are representative of at least
three independent experiments. Arrows indicate normal centrosome, arrowheads in solid indicate centrosome splitting, and open arrowheads indicate centrosome ampliﬁcation.
C. Quantitative analysis of EGF stimulation and LY294002 inhibition of TEIF related centrosome activity. A total of 1000 cells in each group in the above experiments were counted,
and the percentage of centrosome splitting or ampliﬁcation was calculated. Results are summarized from at least three independent experiments. D. The effects of EGF or EGF/
LY294002 on levels of TEIF, Akt and pAkt. Lysates from the above transfected cells were prepared and the level of TEIF (GFP-TEIF or endogenous), Akt and pAktwasmeasured byWestern
blotting (left panel). The quantiﬁcation of results was through calculating the intensity of expression and normalized by β-actin and graphically plotted (right panel). All experiments
were repeated three times independently.
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Fig. 2 (continued).
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and nuclear counterstained with 1 μg/ml DAPI (Sigma-Aldrich). Super-
resolution images of organelle structure were captured by a SIM (Struc-
tured Illumination Microscope) (Nikon SIM Ti-E, Japan) and images
were processed using image processing software (NIS-Elements,
Nikon, Japan).
Both centrosome ampliﬁcation and centrosome splitting were de-
ﬁned according to γ-tubulin staining, and γ-tubulin signals in 1000
counted cells, and≥3 dots of γ-tubulin signal per cell was taken as cen-
trosome ampliﬁcation [11]. Centrosome splitting was recorded when
the distance between two γ-tubulin-stained centrosomes was larger
than 2 μm [43]. The rate of centrosome splitting or ampliﬁcation (%) in
stable HeLa-GFP-TEIF cells was calculated as [cells with centrosome
splitting or ampliﬁcation / cells with GFP-TEIF staining].2.5. Immunoelectron microscopy
HeLa cells were ﬁxedwith 0.1M sodium phosphate buffer (4% para-
formaldehyde, and 0.1% glutaraldehyde) at 4 °C overnight. The samples
were embedded with Lowicryl K4M (BioChemika) and sections were
preparedwith the LEICA EMUC7 ultramicrotome. The sectionswere in-
cubated with rabbit anti-TEIF antibody (1:100) in TBS (pH 7.4) contain-
ing 1% BSA and were further incubated with a mixture of 1:40-diluted
gold particle (10 nm)-conjugated goat anti-rabbit IgG (Sigma-Aldrich)
in TBS (pH 8.2) containing 2% BSA at r.t. for 2 h. Sections were then
stained with saturated uranyl acetate. All sections were observed
under a transmission electron microscope (JEOL-1230, Japan).2.6. Immunoprecipitation and Western blotting
Cells were suspended in RIPA buffer (50 mM Tris–HCl [pH 7.2],
250 mMNaCl, 0.1% Triton-100, 2 mM EDTA, PMSF, and phosphatase in-
hibitor cocktail) for 5 min on ice. Cell extracts were pre-cleared by cen-
trifugation at 12,000 rpm for 10 min at 4 °C, and the supernatant was
shaken with agarose conjugated with anti-GFP (monoclonal antibody,
MBL International Corp.) at 4 °C for 2 h. After ﬂash centrifugation the
precipitates were washed with RIPA buffer ﬁve times for 30 min and
subjected to Western blotting.
Lysates or immunoprecipitation supernatant was resolved on 10%
acrylamide gels by SDS-PAGE and transferred electrically to a PVDF
membrane (Bio-Rad, CA, USA) at 25 V for 90 min. The blots were
blocked in TBST buffer (10 mM Tris–HCl [pH 7.5], 150 mM NaCl, 0.1%
Tween-20) containing 5% (w/v) nonfat drymilk for 60min and then in-
cubated with speciﬁc primary antibodies diluted in TBST buffer at 4 °C
overnight. Membranes were washed three times in TBST and incubated
with horseradish peroxidase-conjugated secondary antibody for 1 h at
room temperature. Membranes were washed ﬁve times and developed
using the ChemiDoc XRS system (Bio-Rad).2.7. In vitro kinase assay
Stably transfected HeLa-GFP-TEIF-ΔFX and HeLa-GFP-TEIF-ΔEF cells
were serum starved for an additional 16 h before harvesting. GFP-TEIFs
were immunoprecipitated from cell extracts and incubatedwith 200 ng
recombinant Akt1 (Cell Signaling Technology) in the presence of
250 mM cold ATP in kinase buffer (Cell Signaling Technology) for 1 h
at 30 °C. The kinase reaction was stopped by the addition of loading
buffer, and the samples were run on 10% SDS-PAGE gel and analyzed
by Western blotting.
2.8. In vitro site-directed mutagenesis
According to the Lightning Site-Directed Mutagenesis method, we
constructed two new mutants. The mutants were derived from a con-
structed plasmid, pEGFP-C3-TEIF-ΔEX, which at the same time served
as the template for polymerase chain reaction (PCR). The mutagenic
oligonucleotide primers (PCR primers) were as follows: ① T469A:
upstream primer 5′-GACA CAGGGTCCTTgCCTCTGCCTTCAGC-3′ and
downstream primer 5′-GCTGAAGGCAGAGGc AAGGACCCTGTGTC-3′;②
T469S: upstream primer 5′-GACACAGGGTCCTTtCCTCTGC CTTCAGC-3′
and downstream primer 5′-GCTGAAGGCAGAGGaAAGGACCCTGTGTC-3′.
The lower case letters mark the nucleotide changes. Mutagenesis proce-
dures were completed in a PCR thermal cycler. PCR reaction was carried
out according to themanufacturer's protocol using the following PCR con-
ditions: 95 °C for 20 s, 60 °C for 10 s; 72 °C extension by TransStart
FastPfu DNA polymerase for 7 min, followed by 17 cycles. The PCR prod-
ucts were then digested by a restriction enzyme—DpnI to remove the pa-
rental DNA (the templates). The resultant plasmids were conﬁrmed by
sequencing and designated as pGFP-TEIF-ΔEXT469A and pGFP-TEIF-
ΔEXT469S.
2.9. Statistical analysis
All data were analyzed with SPSS statistics software (Version 13.0,
Chicago, IL, USA). Relationships between tumor markers and other
parameterswere studied using theχ2-test and Pearson Chi-square, Con-
tinuity Correlation, and Fisher's extract tests. A p-value of less than 0.05
was considered to be statistically signiﬁcant.
3. Results
3.1. Increasing centrosome targeting by TEIF induced centrosome splitting
and ampliﬁcation
Our previous study showed that TEIF localizes in the centrosome in
interphase or mitosis via its C-terminal sequences [42]. Of even
greater interest, centrosome splitting and ampliﬁcation in the stably-
transfected cell lines HeLa-GFP-TEIF-ΔEX and HeLa-GFP-TEIF-ΔHX
1856 J. Zhao et al. / Biochimica et Biophysica Acta 1843 (2014) 1851–1864(Fig. 1A)weremuchmore obvious than those in HeLa andHeLa-GFP-C3
cells, andwere especially prominent in the cell lineHeLa-GFP-TEIF-ΔHX
(Fig. 1B). As shown in Table 1, taking the percentage of centrosomesplitting and ampliﬁcation in HeLa cells as the standard (15% and
2%, respectively), the four lines above all showed higher rates of
splitting and ampliﬁcation, while the rates in HeLa-GFP-TEIF-ΔEF,
1857J. Zhao et al. / Biochimica et Biophysica Acta 1843 (2014) 1851–1864HeLa-GFP-TEIF-ΔEB and HeLa-GFP-C3 were no higher than the HeLa
cell standard.
To conﬁrm the effect of TEIF on centrosome status, ectopic full-
length TEIF was introduced into several cell lines, including HeLa,
MCF-7, PC3Mand U2OS, and their centrosomeswere analyzed by stain-
ing with γ-tubulin. The results showed that over-expression increased
centrosome splitting and ampliﬁcation of HeLa and MCF-7 (Fig. 1C,
upper and lower panels) or PC3M and U2OS cells (data not shown).
These data suggested that increasing centrosome targeting of TEIF
alters centrosome status.3.2. EGF/PI3K signaling stimulates TEIF centrosome targeting
The fact that increasing centrosome targeting of TEIF can alter
centrosome status prompted us to explore the signaling cascade
which regulates TEIF centrosome localization. Bioinformatical analy-
sis on the website http://scansite.mit.edu revealed one consensus
motif for Akt phosphorylation “RHRVLT” at amino acids 464–469 in
TEIF (Fig. 1A) [44,45]. It is noteworthy that this motif was covered
in the constructs which showed capacity for centrosome localization
such as TEIF-ΔEX, -ΔHX, -ΔFX and -ΔFP-1, but was not present in the
vehicles -ΔEF and -ΔEB which showed no TEIF centrosome distribu-
tion. The consensus motif of TEIF (RHRVLT) indicated that EGF/PI3K/
Akt might be involved in TEIF associated centrosome activity. To test
this, HeLa cells or stably-transfected GFP-TEIF-ΔHX (this N-terminal
deleted construct was used in some experiments because it present-
ed more clear centrosome localization with lower background, but
has effects on centrosome similar to those of full-length TEIF
shown in the experiments above), was treated with EGF and the ex-
pression of endogenous and exogenous TEIF and centrosome status
were analyzed. Under EGF treatment (100 ng/ml, 8 h), HeLa
(Fig. 2A) and HeLa-GFP-TEIF-ΔHX cells (Fig. 2B) showed elevated
centrosomal expression of TEIF and an increase in the positive rates
of centrosome splitting and ampliﬁcation (Fig. 2A, B). The addition
of EGF at the same dosage increased centrosome splitting in HeLa
cells from 10% to 32% and increased ampliﬁcation from 1.5 to 6%
(Fig. 2C). In HeLa-GFP-TEIF-ΔHX cells, the EGF-treated HeLa-GFP-
TEIF-ΔHX cells showed an increase in centrosome splitting from
25% to 38%, while the rate of ampliﬁcation increased from 5% to 8%,
in comparison with untreated HeLa-GFP-TEIF-ΔHX cells. Apparently
the differences between the original HeLa cells and the HeLa-GFP-
TEIF-ΔHX cells in centrosome splitting and ampliﬁcation are caused
by increased expression of TEIF in the centrosome. In addition, the
effects of EGF on TEIF and its associated centrosome activity were
veriﬁed with LY294002, a special inhibitor of PI3K which is the key
mediator in the downstream of EGF that triggers signaling and acti-
vates Akt by phosphorylation. Notably, treatment of cells with
LY294002 (10 μM) markedly attenuated EGF-induction of TEIF and
decreased centrosome ampliﬁcation and splitting (Fig. 2A, B, C).
To clarify whether treatment with EGF enhances the total level of
TEIF expression,Western Blotting analysis was performed. As expected,
the addition of EGFmarkedly stimulated pAkt, but did not alter the total
expression of either endogenous or exogenous TEIF expression as
shown in Fig. 2D. Similarly, LY294002 reduced the level of pAkt but
had no effect on TEIF (Fig. 2D). It appears that EGF affectsmainly the dis-
tribution of TEIF but not its expression.
Taken together, these results conﬁrmed that EGF/PI3K can stimulate
the centrosomal distribution of TEIF and alter the associated centro-
some status.Fig. 3. Akt stimulated centrosome expression of TEIF and associated centrosome status. HeLa-G
(Akt1 dominant active) or Akt1-DN (Akt1 dominant negative). A. Representative images for e
WT, Akt1-DAor Akt1-DNwere labeledwith anti-Akt or -pAkt (red). Arrows indicate normal cen
centrosome ampliﬁcation. B. Quantitative results of centrosome splitting or ampliﬁcation in four
of centrosome splitting or ampliﬁcationwere calculated. C. The level of TEIF, Akt, and pAkt in the
three times independently.3.3. Akt activity increases centrosome targeting of TEIF
Akt is the primary mediator in EGF/PI3K signaling, and our analysis
revealed that there is an Akt motif in TEIF. It was therefore reasonable
to suggest that EGF/PI3K regulates TEIF and its associated centrosome
status through Akt. To evaluate this, three plasmids Akt1-WT (wild
type Akt1), Akt1-DA (dominant active, myristylated Akt1 lacking the
pleckstrin homology domain, residues 4–125) and Akt1-DN (dominant
negative Akt1, Akt1-MAA: K179M/T308A/S473A) were used. After
transient transfection into HeLa-GFP-TEIF-ΔEX cells, GFP-TEIF and the
centrosomes in cells with Akt1-WT, Akt1-DA or Akt1-DN were ana-
lyzed. The Akt1-DA group showed much more intense distribution of
GFP-TEIF over the centrosomes, together with increased centrosome
splitting and ampliﬁcation as compared to Akt1-WT or Akt1-DN
(Fig. 3A). The rates of centrosome splitting or ampliﬁcation in the
Akt1-DA groupweremuch higher than those of other groups, especially
the Akt1-DN group (Fig. 3B). However, transfection of Akt1-WT, Akt1-
DA, or Akt1-DN did not change the level of TEIF as analyzed byWestern
blotting (Fig. 3C), although pAkt expression was stimulated remarkably
in both Akt1-WT and Akt1-DA (Fig. 3C). These results indicated that ac-
tivated Akt stimulates centrosome splitting or ampliﬁcation mainly
through TEIF centrosome localization but not by up-regulation of TEIF
global expression.
Perifosine, a new synthetic alkylphospholipid Akt inhibitor, inhibits
Akt activation by targeting the pleckstrin homology domain of Akt [46,
47]. To further evaluate the role of Akt activity in TEIF regulation, a
trial of perifosine as a dose-dependent inhibitor was carried out, in
which HeLa cells were incubated with increasing concentrations of
perifosine (0, 5 μM, 10 μM, 20 μM) for 12 h. As shown in Fig. 4A,
perifosine reduced the level of pAkt in a dose-dependent manner, but
showed no effect on total Akt protein or TEIF levels. At the same time,
the rate of centrosome splitting or ampliﬁcation gradually decreased
with increasing concentrations of perifosine (Fig. 4B). As expected, the
centrosome distribution of TEIF was reduced in the presence of
perifosine (Fig. 4C). However, treatment with perifosine did not reduce
centrosomal distribution of other centrosomal proteins, including
centrin, γ-tubulin, pericentrin, ninein, and so on (data not shown).
This suggested that pAkt regulation of TEIF centrosomal targeting is
speciﬁc.
3.4. Akt1 directly phosphorylates TEIF both in vitro and in vivo
The results from our experiments strongly suggested that Akt plays
an important role in regulation of TEIF. We therefore sought to deter-
mine whether TEIF is a speciﬁc substrate of Akt in vitro and in vivo.
Antibodies speciﬁc for a phosphorylated motif (i.e., phospho-
substrate antibodies) have been valuable in identifying new Akt sub-
strates over the past ﬁve years [48–50]. These antibodies were raised
against degenerate phospho-peptides containing the phosphorylated
form of a small Akt substrate motif (RXRXXS/T) [51]. For in vivo assay,
HeLa-GFP-TEIF-ΔFX (with the RHRVLT-motif) and HeLa-GFP-TEIF-ΔEF
(without the RHRVLT-motif) were treated with EGF (100 ng/ml, 8 h),
followed by immunoprecipitation. The precipitated GFP-TEIF-ΔFX and
GFP-TEIF-ΔEF proteins were then immunoblotted with the pAkt-
MOTIF antibody, and phosphorylation of the pAkt-MOTIF could be de-
tected in HeLa-GFP-TEIF-ΔFX, but not in HeLa-GFP-TEIF-ΔEF (Fig. 5A),
indicating that pAkt could phosphorylate the consensus motif of TEIF
in living cells.
The direct phosphorylation of TEIF by Akt was also conﬁrmed by an
in vitro Akt assay. GFP-TEIFs, GFP-TEIF-ΔFX or GFP-TEIF-ΔEFwas directlyFP-TEIF-ΔEX cells were transiently transfected with Akt1-WT (Akt1 wild-type), Akt1-DA
ach of the four groups. Transfected HeLa-GFP-TEIF-ΔEX cells with vector (control), Akt1-
trosome, arrowheads in solid indicate centrosome splitting, and open arrowheads indicate
transfected groups. A total of 1000 GFP-TEIF-ΔHX cells were counted and the percentages
above transfected cellswasmeasuredbyWestern blotting. All experimentswere repeated
Fig. 4. A. Inhibition of Akt activity by perifosine antagonized EGF stimulation of TEIF-associated centrosome status. HeLa cells were incubated with increasing concentrations of perifosine
(0, 5 μM, 10 μM, or 20 μM) in the presence of EGF (100 ng/ml) for 12 h, and Akt, pAkt and endogenous TEIF were analyzed by Western blotting. B. Quantiﬁcation analysis of centrosome
activity. The percentages of centrosome splitting or ampliﬁcation were calculated after a total of 1000 cells were counted. C. Perifosine reduced centrosome targeting of TEIF. Representative
images fromHeLa cells treatedwith perifosine (5 μM) for 12 h, and stainedwith anti-TEIF (green),γ-tubulin (red) andDAPI (blue) by immunoﬂuorescence. Arrows indicate the centrosomes.
All experiments were repeated independently three times.
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TEIF-ΔEF cells by immunoprecipitation without the addition of EGF.
GFP-TEIF-ΔFX or GFP-TEIF-ΔEFwas incubatedwith puriﬁed recombinant
Akt1 protein. As shown in Fig. 5B, Akt1 efﬁciently phosphorylated GFP-
TEIF-ΔFX, but not GFP-TEIF-ΔEF in this in vitro assay.
To further evaluate Akt-mediated TEIF phosphorylation, out- or in-
phosphorylation was carried out by in vitro site-directed mutagenesis,
in which the 469-threonine in the “RHRVLT” TEIF motif was mutated
to alanine or serine. The mutant constructs pGFP-TEIF-ΔEXT469A and
pGFP-TEIF-ΔEXT469S and wild-type pGFP-TEIF-ΔEX were stably
transfected intoHeLa cells and in vivo phosphorylation assayswere per-
formed in the presence of EGF (100 ng/ml, 8 h) as described above. The
results showed that the phosphorylated TEIF in both pGFP-TEIF-
ΔEXT469S and pGFP-TEIF-ΔEX could bind with the pAkt-MOTIF anti-
body under EGF stimulus, but no signal was found with the group
pGFP-TEIF-ΔEXT469A (Fig. 5C), although elevated pAkt was displayed
in all lysates of these three transfectants. This showed that pAkt
could phosphorylate the 469-threonine (or serine) in the consensus
“RHRVLT” of TEIF.
These results together argue strongly that activated Akt can directly
phosphorylate TEIF, which in turn suggests that TEIF may be a direct
substrate of Akt1.
3.5. Abolition of the phosphorylation site results in decreased centrosome
localization of TEIF and EGF response
To clarify the effects of Akt-mediated TEIF phosphorylation, the mu-
tant constructs pGFP-TEIF-ΔEXT469A and pGFP-TEIF-ΔEXT469S and
wild-type pGFP-TEIF-ΔEX were stably transfected into HeLa cells, and
as expected, the mutation of the TEIF phosphorylation site markedlydecreased centrosomal loading of TEIF, even in the presence of
EGF (Fig. 6A). GFP-TEIF-ΔEXT469A was observed in only a few cells
(5%) while up to 60–70% cells were found in GFP-TEIF-ΔEXT469S and
GFP-TEIF-ΔEX with centrosomal TEIF (Fig. 6B). In addition, abolition of
phosphorylation also caused a decrease in centrosome splitting in cells
with pGFP-TEIF-ΔEXT469A, in comparison with those with pGFP-TEIF-
ΔEXT469S and pGFP-TEIF-ΔEX (p b 0.05) (Fig. 6C). Not unexpectedly,
loss of the EGF response was also signiﬁcant in pGFP-TEIF-ΔEXT469A
transfected cells (p b 0.01) (Fig. 6C). At the same time, centrosome am-
pliﬁcation was slightly decreased in cells with GFP-TEIF-ΔEXT469A (p
N 0.05) with EGF stimulus (Fig. 6D). Nevertheless, there was still some
response in cells with GFP-TEIF-ΔEXT469A, and this may reﬂect the ef-
fect of endogenous TEIF. Consequently, there was a signiﬁcant
difference (p b 0.05) in the formation of bi- or multi-nucleated cells
owing to abnormal mitosis in GFP-TEIF-ΔEXT469A and GFP-TEIF-ΔEX
or GFP-TEIF-ΔEXT469S in the presence of EGF (Fig. 6E).
3.6. Sub-localization of TEIF in the centriole
Centrosome spitting is the loss of connection between paired
centrioles. In order to gain insight into the mechanism of regulation of
centrosome spitting by Akt-coupled TEIF, the sub-localization of
TEIF in centrioles was investigated through analysis of TEIF with other
centrosomal proteins which have distinct locations in the centrosome,
including centrin2 (distal end of the centriole), pericentrin (pericentriolar
matrix), cenexin (appendage), ninein (appendage), and C-NAP1 (proxi-
mal end of centriole). With co-transfection of GFP-TEIF-ΔHX and
DsRed-centrin2, images revealed that GFP-TEIF-ΔHX did not completely
overlap (Fig. 7A, upper panels), and use of super-resolution microscopy
showed that centrin2 separated from TEIF in either unduplicated
Fig. 5. Akt1 phosphorylated TEIF both in vitro and in vivo. A. Akt1 phosphorylated TEIF in vivo. The stable cell lines HeLa-GFP-TEIF-ΔFX (left panel) and HeLa-GFP-TEIF-ΔEF (right panel)
were serum starved for 16 h before treatment with EGF (100 ng/ml, 8 h). GFP-tagged TEIF was immunoprecipitated with anti-GFP antibody and immunoblotted with the pAkt-MOTIF
antibody. B. Akt1 phosphorylated TEIF in vitro. The stable cell lines HeLa-GFP-TEIF-ΔFX (left) and HeLa-GFP-TEIF-ΔEF (right) were serum starved for 16 h and TEIF was
immunoprecipitated from cell extracts and incubated with 200 ng recombinant Akt1 (Cell Signaling Technology) in the presence of 250 mM of cold ATP in a kinase buffer for 1 h at
30 °C. The kinase reaction was stopped by the addition of SDS-PAGE loading buffer, and samples were immunoblotted with the pAkt-MOTIF antibody. C. The introduced mutation in
the consensus site abolished pAkt-mediated phosphorylation of TEIF. The 469-threonine in the consensus “RHRVLT” of wild-type pGFP-TEIF-ΔEX was mutated into alanine or serine to
generate constructs pGFP-TEIF-ΔEXT469A and pGFP-TEIF-ΔEXT469S. These constructs were stably transfected into HeLa cells and in vivo phosphorylation assays were performed in
the presence of EGF (100 ng/ml, 8 h) as above. The levels of phosphorylated TEIF in pGFP-TEIF-ΔEX, pGFP-TEIF-ΔEXT469A and pGFP-TEIF-ΔEXT469S were measured by the
pAkt-MOTIF antibody. All results are representative of three independent experiments.
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trioles. In contrast, TEIF showed nearly complete co-localization
with C-NAP1 (Fig. 7B, upper panels). Super-resolution imaging con-
ﬁrmed this co-localization of C-NAP1 with TEIF in pre-duplicated cen-
trioles (Fig. 7B, lower panels, I), and also more clearly showed that C-
NAP1 in duplicated centrioles still largely overlapped with TEIF and
was more closely located between two centrioles (Fig. 7B, lower panels,
II). As centrin2 and C-NAP1 localize in the distal ends and proximal ends
of centrioles respectively, based on the above results TEIF should localize
in the proximal ends of centrioles. To conﬁrm this, immuno-electronmi-
croscopy was performedwhich demonstrated that TEIFmainly localized
in the proximal ends of centrioles (Fig. 7C). The relative location ofcentrin2, TEIF and C-NAP1 is summarized and depicted in a sketch
(Fig. 7D).
3.7. Increased centrosome targeting of TEIF alters the distribution of C-NAP1
C-NAP1 which is located in the proximal ends of the centriole is an
important factor for maintaining cohesion of centrioles in interphase
[43]. Upon phosphorylation of C-NAP1 by Nek2 which occurs in the
late G2 phase, C-NAP1 departs from the proximal centriole ends and
triggers the separation of paired centrioles. Abnormal C-NAP1 can result
in centriole splitting with premature separation of centrosomes [43].
Because TEIF localizes closely with C-NAP1, the effects of TEIF
Fig. 6. A. The abolition of phosphorylation of TEIF decreased the centrosomal loading of TEIF. The images are representative of HeLa cells, which were transfected with pGFP-TEIF-ΔEX
(ΔEX), pGFP-TEIF-ΔEXT469S (ΔEX-T469S) and pGFP-TEIF-ΔEXT469A (ΔEX-T469A) without (left panels) or with treatment of EGF (100 ng/ml, right panels) for 12 h and were labeled
withγ-tubulin (red). Arrows indicate normal centrosomes, arrowheads in solid indicate centrosome splitting, and open arrowheads indicate centrosome ampliﬁcation. B. The percentages
of TEIF localizing in the centrosomewere calculated by random counting 1000 cells from each of the above three kinds of HeLa cells (cells showing GFP signal in the centrosome/1000 cells
withγ-tubulin signal). The data represent an average of three independent experiments. C, D and E. The abolition of the phosphorylation site of TEIF antagonized effects of EGF stimulation.
Centrosome splitting (C), ampliﬁcation (D) and abnormal mitosis (E, bi- or multi-nucleated cells) were calculated based on counting 1000 cells in each kind of the above transfections. All
results are representative of at least three independent experiments.
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TEIF (GFP-TEIF-ΔHX), reduced C-NAP1 centrosomal localization was
observed in GFP-TEIF-ΔHX transfected cells (Fig. 8A, cells with GFP) in
comparison to untransfected cells (Fig. 8A, control panel, asterisksindicate cells). In the presence of EGF, cells with increased centrosomal
TEIF (GFP-TEIF-ΔHX) showed reduced C-NAP1 (Fig. 8A, EGF panels).
And as expected, the untransfected cells with EGF-treatment (Fig. 8A,
EGF panels, asterisks indicate cells) showed reduced C-NAP1 as
Fig. 7. Analysis of subcentriolar localization of TEIF. A. The relative localization of centrin2 and TEIF. Co-transfection of HeLa cells with GFP-TEIF-ΔHX (GFP-ΔHX) and pDsRed-centrin2
(RFP-Cnt2). Upper panels: conventional ﬂuorescentmicroscopy. Lower panels: super-resolutionmicroscopy by SIM. I: unduplicated centrosome; II: duplicated centrosome. B. The relative
localization of TEIF and C-NAP1. GFP-TEIF-ΔHX (GFP-ΔHX) transfectedHeLa cells were stainedwith C-NAP1 (red). Upper panels: conventional ﬂuorescentmicroscopy. Lower panels: SIM
microscopy. I: unduplicated centrosome; II: duplicated centrosome. C. Image from immuno-electron microscopy. Inserted window: illustration of the centrosome and sub-localization of
TEIF. D. Sketch summarizing the relative localization of centrin2, C-NAP1 and TEIF in the centrioles.
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indicate cells). Similarly, in comparison withwild-type (GFP-TEIF-ΔEX)
or GFP-TEIF-ΔEXT469S, cells with phosphorylation site-mutated
GFP-TEIF-ΔEXT469A also presented about 1.5 fold increase of C-NAP1
in the centrosome (Fig. 8B), implying that the decrease of centrosomal
TEIF could increase C-NAP1.
These results indicate that increasing centrosome loading of TEIF
could result in displacement of C-NAP1.
4. Discussion
Although activation of EGF/Akt is a frequently identiﬁed event
in tumorigenesis, there have been fewdescriptions of its activity related
to centrosome ampliﬁcation. In the early 1980s, Sherline and Mascardo
reported that the addition of EGF enhances the separation of centro-
somes [34,35]. However, it has been only recently that molecularevidence has emerged showing Akt together with other proteins is re-
sponsible for EGF/PI3K/Akt signaling which regulates centrosome
activity [36–39]. In particular, Mardin et al. recently showed that EGF
can induce premature centrosome separation in the early S phase and
consequently promote proliferation and survival of cells [38]. In a genet-
icmodel, Buttrick et al. discovered that Akt1 is necessary for centrosome
migration and spindle orientation in the early D. melanogaster embryo
by acting through GSK-3 (glycogen synthase kinase-3) [36]. In addition,
activation of Aurora-A kinase by Akt has proved to induce centrosome
ampliﬁcation and consequent chromosome abnormality in cancer cells
[32,33]. Thus, the signaling pathway consisting of Akt kinase and its
upstream or downstream regulators has come to be understood as an
important part of the machinery for centrosome activity.
Coupledwith cell cycle progression, one centrosome cycle undergoes
sequential events including centriole disengagement, centriole duplica-
tion, centriole elongation, and centrosome separation and maturation,
Fig. 8. Centrosome loading of TEIF could displace C-NAP1. A. EGF-stimulation of TEIF reduced C-NAP1 centrosome localization. HeLa cells were transfected with GFP-TEIF-ΔHX and incu-
bated with EGF (100 ng/ml) for 8 h and were stained with C-NAP1 (red) by immunoﬂuorescence. The asterisks indicate untransfected cells. B. Reduced centrosome expression of TEIF
lacking a phosphorylation site increased C-NAP1 localization. HeLa cells transfected with GFP-TEIF-ΔEX, GFP-TEIF-ΔEXT469S, and GFP-TEIF-ΔEXT469A were stained with C-NAP1
(red). Arrows indicate normal centrosome, and arrowheads in solid indicate centrosome splitting. The results are representative of three independent experiments.
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somes [18,52]. Prior to the onset of mitosis, duplicated centrosomes are
believed to be connected through a linker. This cohesion may be impor-
tant for protection of the centrosome from abnormal duplication and for
maturation of daughter centrosomes, while disjunction of connected
centrosomes is necessary for separation as well as migration in the late
G2 phase [18,19,52]. Cohesion results from a proteinaceous linker
which connects the proximal centrosome ends, and C-NAP1, rootletin
and β-catenin localize and are believed to be involved in centrosome co-
hesion [19,43]. In addition to C-NAP1 and rootletin, other centrosomal
proteins such as Cep68 and Cep215 (CDK5RAP2) have also been identi-
ﬁed as possible linker proteins [19]. Displacement of linker proteins is
proposed to regulate cohesion status, where localization of linker pro-
teins enhances cohesion while their displacement induces disjunction
[43]. The distribution of linker proteins is determined by the balance be-
tween phosphorylation and dephosphorylation of Nek2a kinase and
PP1γ phosphatases [43]. It has been established that Nek2 kinase and
C-NAP1 are major regulators which trigger centrosome splitting or sep-
aration [43]. Recently it has been revealed that EGF can induce centro-
some separation via stimulation of Nek2a activity [38]. Centrosome
splitting is the premature separation of centrosomes in interphase, and
splitting may therefore reﬂect a defect in centrosome cohesion or anunscheduled separation [19]. A link between centrosome splitting and
ampliﬁcation has in fact been documented, indicating that disruption of
cohesion may cause premature centrosome splitting and consequently
result in centrosome ampliﬁcation. For example, β-catenin which is
a key factor in Wnt-signaling is involved in centrosome cohesion.
Inactivated β-catenin maintains a status of centrosome cohesion, but
β-catenin is activated upon the decrease of GSK-3β kinase phosphoryla-
tion and induces centrosome splitting and ampliﬁcation [53]. Over-
expression of Sik2, a kinase which acts in the regulation of centrosome
cohesion, may also induce centrosome splitting and ampliﬁcation in
ovarian cancers [54]. More convincingly, centrosome splitting has
been considered amajor step in DNA damage-induced centrosome am-
pliﬁcation [55]. Nevertheless, it is unclear how loss of cohesion causes
centrosome ampliﬁcation. Some evidence shows that prematurely
split centrosomes are prone to recruit procentriolar materials [18,20].
In this study our ﬁndings suggest that TEIF localizes at the proximal
ends of centrosomes close to C-NAP1, showing that TEIF may play a
role in the regulation of centrosome cohesion, as increased centrosomal
expression of TEIF induces centrosome splitting in addition to centro-
some ampliﬁcation. Moreover, these results also highlight a possible
TEIF function by which Akt signaling is linked with centrosome cohe-
sion, which consists of increased centrosomal targeting of TEIF
1863J. Zhao et al. / Biochimica et Biophysica Acta 1843 (2014) 1851–1864stimulated by EGF or activated Akt induced centrosome splitting. Nev-
ertheless, the more detailed investigation of the mechanism of regula-
tion of centrosome activity by TEIF is warranted, and should include
the evaluation of integration of TEIF with other centrosomal proteins,
interaction between TEIF and C-NAP1, and so on. It is worthmentioning
that Nakamura et al. described Aki1 (Akt kinase-interacting protein 1)
which localizes at the centrosome and regulates centrosome cohesion,
suggesting functional involvement of Akt in centrosome cohesion
[37]. Thus, exploration of the interaction of TEIF and Nek2a or C-NAP1
may provide further evidence regarding the role TEIF plays in centro-
some cohesion and/or separation.
In summary, the present investigation provides a bridge linking EGF/
PI3K/Akt signaling and centrosome status in tumorigenesis. Considering
the prevalence of EGF/PI3K/Akt signaling in human cancers, it is reason-
able to believe that the role of TEIF not onlywill open a newwindow for
viewing the mechanism of oncogenic signaling in cancer development,
but alsowill cast a new light on potentialmolecules for targeted therapy
in human cancers.
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